top of page
SPEAKER INFORMATION
Olivier Danos
RegenX bio
Olivier Danos is Executive Vice President and Chief Scientific Officer at REGENXBIO. His pioneering research work has led to the development of gene transfer technologies for gene therapy. He has played leadership roles in the Cell and Gene Therapy biopharma space, including at Biogen, Genethon and at major research institutions (University College of London, Paris Necker Hospital, Centre National de la Recherche Scientifique and Institut Pasteur). He is a founding member and a past President (1996 – 2000) of the European Society of Gene Therapy. He received a Lifetime Achievement Award from ESGCT in 2005

bottom of page